diphenhydramine has been researched along with Movement Disorders in 14 studies
Diphenhydramine: A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects.
diphenhydramine : An ether that is the benzhydryl ether of 2-(dimethylamino)ethanol. It is a H1-receptor antagonist used as a antipruritic and antitussive drug.
antitussive : An agent that suppresses cough. Antitussives have a central or a peripheral action on the cough reflex, or a combination of both. Compare with expectorants, which are considered to increase the volume of secretions in the respiratory tract, so facilitating their removal by ciliary action and coughing, and mucolytics, which decrease the viscosity of mucus, facilitating its removal by ciliary action and expectoration.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although diphenhydramine hydrochloride is known to eliminate or reduce the symptoms of dystonia in human patients with acute dystonic reactions and idiopathic torsion dystonia, its mechanism of action is still unclear." | 3.69 | Evidence for the involvement of histamine in the antidystonic effects of diphenhydramine. ( Matsumoto, RR; Stone, MR; Truong, DD; van't Groenewout, JL; Vo, VN, 1995) |
| "Metoclopramide was discontinued and diphenhydramine 50 mg was initially administered intravenously followed with 25 mg orally every 4 hours as needed." | 1.38 | Tardive dyskinesia after short-term treatment with oral metoclopramide in an adolescent. ( Karimi Khaledi, M; Shelton, CM; Suda, KJ, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (64.29) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sawicka, KM | 1 |
| Goez, H | 1 |
| Huntsman, RJ | 1 |
| Karimi Khaledi, M | 1 |
| Suda, KJ | 1 |
| Shelton, CM | 1 |
| FREED, H | 1 |
| DRAPER, IT | 1 |
| JOHNS, RJ | 1 |
| Hermann, DM | 1 |
| Bassetti, CL | 1 |
| van't Groenewout, JL | 1 |
| Stone, MR | 1 |
| Vo, VN | 1 |
| Truong, DD | 1 |
| Matsumoto, RR | 1 |
| Connor, DF | 1 |
| Benjamin, S | 1 |
| Ozbayrak, KR | 1 |
| Sögtrop, HH | 1 |
| Weise, HT | 1 |
| Kirschberg, GJ | 1 |
| Beitman, BD | 1 |
| Berk, BZ | 1 |
| Sananman, ML | 1 |
| Guggenheim, MA | 1 |
| Dodge, PR | 1 |
| Eisenberg, L | 1 |
14 other studies available for diphenhydramine and Movement Disorders
| Article | Year |
|---|---|
Successful Treatment of Paroxysmal Movement Disorders of Infancy With Dimenhydrinate and Diphenhydramine.
Topics: Dimenhydrinate; Diphenhydramine; Electroencephalography; Histamine H1 Antagonists; Humans; Infant; M | 2016 |
Tardive dyskinesia after short-term treatment with oral metoclopramide in an adolescent.
Topics: Administration, Oral; Adolescent; Age Factors; Antiemetics; Diphenhydramine; Drug Administration Sch | 2012 |
On special uses of diphenhydramine hydrochloride in the somatic therapy ward of a psychiatric hospital.
Topics: Diphenhydramine; Electroconvulsive Therapy; Hospitals, Psychiatric; Humans; Movement Disorders; Naus | 1958 |
THE DISORDERED MOVEMENT IN PARKINSONISM AND THE EFFECT OF DRUG TREATMENT.
Topics: Atropine; Dextroamphetamine; Diphenhydramine; Drug Therapy; Geriatrics; Humans; Kinetics; Motor Skil | 1964 |
Reversible opsoclonus after diphenhydramine misuse.
Topics: Adult; Diphenhydramine; Female; Humans; Hypnotics and Sedatives; Movement Disorders; Ocular Motility | 2005 |
Evidence for the involvement of histamine in the antidystonic effects of diphenhydramine.
Topics: Animals; Diphenhydramine; Disease Models, Animal; Dose-Response Relationship, Drug; Dystonia; Halope | 1995 |
Case study: neuroleptic withdrawal dyskinesia exacerbated by ongoing stimulant treatment.
Topics: Antipsychotic Agents; Dextroamphetamine; Diphenhydramine; Fluoxetine; Humans; Male; Mental Disorders | 1995 |
[Results of treatment with DoloVisano for non-specific pain syndrome related to body movement. Concluding report on a field study of 3326 patients by 314 orthopedists].
Topics: Aspirin; Codeine; Diphenhydramine; Drug Combinations; Drug Evaluation; Humans; Meprobamate; Movement | 1979 |
Dyskinesia-an unusual reaction to ethosuximide.
Topics: Adolescent; Diphenhydramine; Epilepsy, Absence; Ethosuximide; Female; Humans; Movement Disorders | 1975 |
Diphenhydramine in the differential diagnosis of neuroleptic-induced oral-facial dyskinesia.
Topics: Adult; Diagnosis, Differential; Diphenhydramine; Dyskinesia, Drug-Induced; Female; Humans; Movement | 1977 |
Reaction to prochlorperazine?
Topics: Adolescent; Child; Diphenhydramine; Female; Humans; Male; Movement Disorders; Prochlorperazine; Spas | 1969 |
Letter: Dyskinesia after fenfluramine.
Topics: Adult; Diphenhydramine; Female; Fenfluramine; Humans; Injections, Intravenous; Movement Disorders; T | 1974 |
Unusual arm movements with onset in childhood--a nosologic entity?
Topics: Child; Diagnosis, Differential; Diazepam; Dihydroxyphenylalanine; Diphenhydramine; Dystonia Musculor | 1970 |
The management of the hyperkinetic child.
Topics: Child; Child, Preschool; Chlorpromazine; Dextroamphetamine; Diphenhydramine; Environment; Family; Hu | 1966 |